EDGAR Filing Documents for 0001654954-18-006212

Form 8-K - Current report:

SEC Accession No. 0001654954-18-006212

Filing Date

2018-06-01

Accepted

2018-06-01 17:28:43

Documents

Period of Report

2018-05-29

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	azrx8k_may292018.htm	8-K	31229
2	PRESS RELEASE	ex99-1.htm	EX-99.1	10713
	Complete submission text file	0001654954-18-006212.txt		43248

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 18876123
SIC: 2834 Pharmaceutical Preparations